Skip to content

Company information lookup


biotechnology and medical research

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PRR 0.037 -2.63% 0.037 0.038 0.038 0.038 0.036 3,829,020


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PRR
Official Listing Date 23 June, 1988
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address
Registered Office Address Level 7, 151 Macquarie Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone +61 2 9276 1224
Head Office Fax (02) 9276 1284
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Ms Lucy Turnbull A.O. (Chairman)
Mr Albert Wong (Deputy Chairman, Non Exec. Director)
Mr Matthew Lehman (CEO, Executive Director)
Dr Russell John Howard (Non Exec. Director)
Mr Pete Meyers (Non Exec. Director)
Mr Marc Voigt (CFO)
Ms Deanne Miller (General Counsel)
Ms Sandra Lee (Investor Relations)
Company Secretary Ms Deanne Miller
Principal Activities biotechnology and medical research

PRIMA BIOMED LTD announcements

How are company announcements published on

Date Price
Headline Pages PDF
07/04/2014   Prima to present at Needham Healthcare Conference 1 PDF
28/03/2014 asterix CVac Improvement in 2nd Remission Data Accepted for ASCO 2 PDF
25/03/2014   New Appointments to Clinical Advisory Board 2 PDF
07/03/2014 asterix S&P DJ Indices Announces March Quarterly Rebalance 10 PDF
05/03/2014 asterix $1.6 million R&D Tax Incentive Refund Received 1 PDF
27/02/2014   Prima to present at Regen Med Investor Day 2 PDF
27/02/2014   Prima to present at Wall Street Analyst Forum 2 PDF
21/02/2014 asterix Prima and Neopharm execute final CVac licensing agreement 2 PDF
20/02/2014   Dr Monk to Join Prima BioMed Clinical Advisory Board 2 PDF
18/02/2014 asterix Half Yearly Report and Accounts 22 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
22 Apr 2014 0.038 -2.56% 0.039 0.038 439,994
17 Apr 2014 0.039 2.63% 0.039 0.038 852,078
16 Apr 2014 0.038 -2.56% 0.039 0.038 748,882
15 Apr 2014 0.039 0% 0.039 0.038 888,815
14 Apr 2014 0.039 0% 0.039 0.038 714,585

* Volume of shares shown represents only those shares traded on ASX.

PRIMA BIOMED LTD price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security PRR. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PRR

Warrants & Structured Products

No warrants & Structured Products are available over the security PRR


No Contracts For Differences are available over the security PRR